Big Week Coming, page-102

CJTJ - What in your research made you think SUDA was the company to invest in:

Was it the Teva deal - the Eddingpharma deal - the Stride deal - the Zelda deal - that you believe .005 is the bottom for the SP.

or was it the missed timelines - the continued need to do cr - the small up front payments - the small milestone payments - the fact that so far neither Teva or Eddingpharma have gotten approval for Zolpimist, a product which is already commercialised in the US - Was it that SUDA havent even submitted a MAA for Zolpimist which was expected to be submitted over 12 months ago - The fact that the Australian MAA for Artimist is running over 12 months late - that the sp has fallen over 90% in 3 years - That there is over 2.5B shares on issue - the lack of progress with pfizer, the lack of progress since 2015 with approval applications for SUD-001, SUD-002, SUD -003 (See announcement dated 8 Feb 2016).